Semiconductor Short Interest Remains Mixed
The December 15 short interest data have been compared with the previous report. Short interest moves were mixed in these selected semiconductor stocks.
All Work
Chris Lange
Short Interest Rises in Major Pharma
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Biotech Short Interest Sinks
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
Short Sellers Back Off Cybersecurity Stocks
The December 15 short interest data have been compared with the previous figures, and short interest moves in the selected cybersecurity stocks was mixed.
Short Interest in Social Media Stocks Falls
The December 15 short interest data have been compared with the previous report. Short interest moves in these selected social media stocks were mostly down for this settlement date.
Major Oil Short Interest Remains Mixed
The December 15 short interest data have been compared with the previous figures, and short interest moves for the selected oil stocks was mixed.
Teva Agrees to Pay Over $500 Million for FCPA Violations
The SEC has announced that Teva Pharmaceutical Industries has agreed to pay over $519 million to settle charges that it violated the Foreign Corrupt Practices Act by paying bribes to foreign government officials.
Amphastar Slides After Receiving CRL From the FDA
Shares of Amphastar Pharmaceuticals fell on Tuesday after the company announced that a subsidiary had received a Complete Response Letter from the FDA.
Endologix Sinks on Temporary Shipping Hold
Although the week between Christmas and New Year’s is not a heavily traded one, one company is making a case for it with a double-digit move on Tuesday.
Milacron Files for Secondary Offering
Milacron has filed with the SEC regarding a secondary offering, though no pricing details were given in the filing.
Bed Bath & Beyond Sinks on Earnings
Bed Bath & Beyond shares sank after the retailer reported its fiscal third-quarter financial results late on Wednesday.
SEC Charges Phony Day-Trading Firm
The SEC has charged two men behind a phony day-trading firm with pocketing more than $1 million in deposits from hundreds of defrauded investors worldwide.
Red Hat Gets Crushed on Earnings and CFO Departure
After the markets closed on Wednesday, Red Hat reported mixed fiscal third-quarter financial results and announced the departure of its chief financial officer.
Visterra Gears Up for IPO
Visterra has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Kleopatra Files for IPO
Kleopatra Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Rite Aid Slips on Earnings Miss
Rite Aid reported disappointing fiscal third-quarter financial results before the markets opened on Thursday.
Micron Rises on Earnings Beat
Micron Technology, Inc. (NASDAQ: MU) reported fiscal first-quarter financial results after markets closed on Wednesday. The company posted $0.32 in earnings per share (EPS) and $3.97 billion in revenue. The consensus estimates from Thomson…
SEC Settles FCPA Charges With Brazil-Based Petro-Manufacturer
The U.S. Securities and Exchange Commission (SEC) recently announced that a Brazilian-based petrochemical manufacturer whose stock trades in the U.S. markets has agreed to settle charges that it created false books and records to…
Morgan Stanley Settles SEC Charges of Customer Protection Rule Violations
The SEC has announced that Morgan Stanley has agreed to pay more than $7 million to settle charges it used trades involving customer cash to lower the firm’s borrowing costs in violation of the…
Merrimack Pharmaceuticals Stops Mid-Stage Breast Cancer Trial
Shares of Merrimack Pharmaceuticals dropped on Wednesday after the company reported that it would stop a mid-stage cancer study.